Phase Forward Introduces Phase Forward IRT 5.0 IRT Solution
According to the company, Phase Forward IRT 5.0 gives managers direct control over clinical supply management and helps to provide assurance of supply availability at randomization. Phase Forward IRT also offers a new integrated drug forecasting module for advanced global clinical trial supply management and a new, enhanced user interface to streamline navigation and consolidate workflow.
The company has added that the Phase Forward IRT 5.0 release introduces a new smart system intelligence feature that puts clinical supply managers in control, helping them effectively respond to sudden increases in new subjects at any point in the trial.
On the basis of user-defined variables, the application will either automatically generate a supply order or notify the supply manager of a potential stock-out, ensuring that subject enrollment is not compromised by lack of study supplies.
The company has also added that the new integrated drug forecasting module gives managers pre-study planning tools to optimize trial supply strategies. During live trials the application links to trial data on demand, enabling managers to compare planning assumptions and forecasts with actual trial data, update supply demand assumptions as needed and modify manufacturing schedules to respond to new projections.
The company has more added that together, Phase Forward’s IRT and InForm GTM electronic data capture (EDC) solutions offer users a tightly integrated solution with a single, unified interface and seamless workflow, providing the total cost of ownership and single point of contact benefits inherent in a single vendor solution.
Steve Rosenberg, senior vice president of products and services at Phase Forward, said: “Phase Forward IRT 5.0 is a major step forward in helping customers leverage the power of IRT technology to improve efficiency within clinical trial supply management and planning, a crucial factor in every trial’s success, this release is a key component of our integrated clinical research suite for end-to-end clinical trial management.”
Do you think Phase Forward IRT 5.0 can find success in the market?
Have your say and discuss with your peers on the InfoGrok community.
Participate by posting your comments now.